Phenominer Database Results (9 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
BDIX percentage of study population displaying trigeminal nerve neurilemmomas at a point in time N-ethyl-N-nitrosourea (80 ug/g) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. trigeminal nerve integrity trait male 200 days 57 55.0 % 0.89 6.75 in vivo visual assessment 0.0 0 inferred from Kaplan-Meier plot analysis SD approximated from 95%CI 98142 2018
BDIX post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors N-ethyl-N-nitrosourea (80 mg/kg) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. life span trait both 190 days-213 days 109 Kaplan Meier estimate median 201.0 d 0.55 5.75 necropsy 0.0 0 SD approximated from 95%CI 98127 2018
BDIX ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time N-ethyl-N-nitrosourea (80 mg/kg) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. life span trait female 200 days 52 59.0 % 1.07 7.75 in vivo visual assessment 0.0 ENU injection 200 days PI time in S1 ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) 98159 2018
BDIX post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors N-ethyl-N-nitrosourea (80 mg/kg) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. life span trait male 181 days-213 days 57 Kaplan Meier estimate median 197.0 d 1.06 8.0 necropsy 0.0 0 SD approximated from 95%CI 98125 2018
BDIX post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors N-ethyl-N-nitrosourea (80 mg/kg) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. life span trait female 192 days-236 days 52 Kaplan Meier estimate median 214.0 d 1.53 11.0 necropsy 0.0 0 SD approximated from 95%CI 98126 2018
BDIX percentage of study population displaying trigeminal nerve neurilemmomas at a point in time N-ethyl-N-nitrosourea (80 ug/g) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. trigeminal nerve integrity trait female 200 days 52 41.0 % 1.07 7.75 in vivo visual assessment 0.0 0 inferred from Kaplan-Meier plot analysis SD approximated from 95%CI 98143 2018
BDIX percentage of study population displaying trigeminal nerve neurilemmomas at a point in time N-ethyl-N-nitrosourea (80 ug/g) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. trigeminal nerve integrity trait both 200 days 109 49.0 % 0.48 5.0 in vivo visual assessment 0.0 0 inferred from Kaplan-Meier plot analysis SD approximated from 95%CI 98144 2018
BDIX ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time N-ethyl-N-nitrosourea (80 mg/kg) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. life span trait male 200 days 57 45.0 % 0.66 5.0 in vivo visual assessment 0.0 ENU injection 200 days PI time in S1 ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) 98158 2018
BDIX ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time N-ethyl-N-nitrosourea (80 mg/kg) van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. life span trait both 200 days 109 51.0 % 0.48 5.0 in vivo visual assessment 0.0 ENU injection 200 days PI time in S1 ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) 98160 2018